Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
311.5 USD | +0.15% |
|
-2.25% | +8.37% |
04:39pm | Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints | MT |
27/06 | Argus Raises Amgen's Price Target to $340 From $300 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.37% | 167B | |
+55.07% | 823B | |
+42.31% | 641B | |
-6.84% | 352B | |
+17.21% | 324B | |
+7.60% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
-3.07% | 160B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Transcript : Amgen Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 11